Jany Moussa, MD
Nephrology · Wichita, KSNPI 1861443459
Payments from drug & device makers
Across 201 payments — averaging $3943.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$509K
- Bayer$281K
- Amgen$376
- Travere Therapeutics, Inc.$280
- Novartis$157
- Mallinckrodt Enterprises LLC$138
- plus $1K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 15 | $509,202 |
| Bayer | 87 | $281,215 |
| Amgen | 12 | $376 |
| Travere Therapeutics, Inc. | 13 | $280 |
| Novartis | 7 | $157 |
| Mallinckrodt Enterprises LLC | 2 | $138 |
| Medtronic | 1 | $123 |
| Vifor Pharma, Inc. | 6 | $120 |
| Alnylam Pharmaceuticals Inc. | 3 | $113 |
| Calliditas Therapeutics US Inc. | 5 | $108 |
| Akebia Therapeutics Inc | 8 | $108 |
| OPKO Pharmaceuticals, LLC | 7 | $105 |
| Novo Nordisk | 4 | $88 |
| Fresenius USA Marketing, Inc. | 5 | $78 |
| GSK | 5 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Mallinckrodt Hospital Products Inc. | 3 | $51 |
| Aurinia Pharma U.S., Inc. | 3 | $50 |
| Boehringer Ingelheim | 2 | $47 |
| Shire North American Group Inc | 2 | $36 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $18 |
| Nxstage Medical, Inc. | 1 | $17 |
| Sanofi | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $12 |
How this compares
$792,663 in reported general payments places this provider in the 95th percentile of 55 nephrology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Wichita
- Dennis RossWichita$2.1M
- Lisa WeberWichita$133K
- Edgard WehbeWichita$59K
- Mohamad SandidWichita$8K
- Amanda ValliantWichita$3K
- Ushasri ChallaWichita$3K
- Joseph MeouchyWichita$2K
- Michael GrantWichita$2K
- Levi ShortWichita$1K
- Kenneth KovachWichita$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.